GlobalData on MSN
Genmab reports top line results in Phase III DLBCL trial
Genmab plans to present full results at an upcoming medical meeting.
Clinical Trials Arena on MSN
Roche reports positive top line phase II data for CT-388 in obesity
Participants receiving up to 24mg of CT-388 had a placebo-adjusted weight loss of 22.5% at 48 weeks.
Onvansertib combined with FOLFIRI and Avastin shows dose-dependent improvements in tumor response and disease control for RAS ...
Advanced gastroesophageal adenocarcinoma (GEA) with HER2 positivity has long presented significant treatment challenges, with ...
Onvansertib added to FOLFIRI/bev first-line standard of care regimen showed dose-dependent improvement in overall response rates and durability trends as measured by progression-free survival in patie ...
In Both Acute Pain Models, MR-107A-02 Demonstrated Statistically Significant and Clinically Meaningful Improvement in Pain Compared to Placebo, Significant Reduction in Opioid Usage and Superior Pain ...
Phase shifters and transmission line technologies are integral components in modern RF and microwave engineering, enabling precise control of signal phase for applications ranging from beamforming in ...
PITTSBURGH — The second phase of the ongoing University Line project is moving forward. Pittsburgh Regional Transit announced on Friday that a $99.8 million construction contract had been awarded to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results